Literature DB >> 14397903

Long-term acetazoleamide (diamox) administration in therapy of glaucomas.

B BECKER, W H MIDDLETON.   

Abstract

Entities:  

Keywords:  DIURETICS/therapeutic use; GLAUCOMA/therapy; HYDRASES

Mesh:

Substances:

Year:  1955        PMID: 14397903     DOI: 10.1001/archopht.1955.00930020191004

Source DB:  PubMed          Journal:  AMA Arch Ophthalmol        ISSN: 0096-6339


× No keyword cloud information.
  13 in total

1.  TOXICITY OF ACETAZOLAMIDE.

Authors:  D W DAVIES
Journal:  Br Med J       Date:  1963-11-09

2.  Acetazolamide therapy with renal complications.

Authors:  D W DAVIES
Journal:  Br Med J       Date:  1959-01-24

3.  Combined action of diamox and potassium bicarbonate in the treatment of of chronic glaucoma.

Authors:  D A CAMPBELL; M JONES; N E RENNER; E L TONKS
Journal:  Br J Ophthalmol       Date:  1957-12       Impact factor: 4.638

4.  GLAUCOMA TREATED WITH DARANIDE A CLINICAL TRIAL.

Authors:  M H Luntz
Journal:  Br J Ophthalmol       Date:  1961-02       Impact factor: 4.638

5.  Comparison of the effect of acetazolamide tablets and sustets on diurnal intraocular pressure in patients with chronic simple glaucoma.

Authors:  P W Joyce; K B Mills
Journal:  Br J Ophthalmol       Date:  1990-07       Impact factor: 4.638

6.  Equivalence of conventional and sustained release oral dosage formulations of acetazolamide in primary open angle glaucoma.

Authors:  P W Joyce; K B Mills; T Richardson; G E Mawer
Journal:  Br J Clin Pharmacol       Date:  1989-05       Impact factor: 4.335

7.  Urinary calculi with methazolamide therapy.

Authors:  P P Ellis
Journal:  Doc Ophthalmol       Date:  1973-02-21       Impact factor: 2.379

8.  Fatal reaction to acetazolamide.

Authors:  A Kristinsson
Journal:  Br J Ophthalmol       Date:  1967-05       Impact factor: 4.638

9.  The aetiology of renal stone: a new concept arising from studies on a stone-free population.

Authors:  M Modlin
Journal:  Ann R Coll Surg Engl       Date:  1967-03       Impact factor: 1.891

Review 10.  Prevention and management of drug-induced peripheral neuropathy.

Authors:  L L Olesen; T S Jensen
Journal:  Drug Saf       Date:  1991 Jul-Aug       Impact factor: 5.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.